Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
MYOCENE from Liège, company number BE0746696102, closed financial year 2025 with a result of € -1.1 million after tax. For that financial year MYOCENE recorded revenue of € 297,061 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € -705,291 to € -1.1 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
€ 1.3 million
▼ 48% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1.1 million
▼ 63 % more loss than in 2024
Profit after tax over the fiscal year.
€ 698,127
▼ 70% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -2.8 million.
People and assets in 2025
€ 435,023
▲ 15% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,101
▼ 44% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.9 million
Loans from banks and other lenders, long and short.
€ 37,900
▼ 56% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 52,828
▼ 7% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 7,739 | € 61,492 | € 210,181 | € 297,061 | ▲ 41% |
| Gross margin | € -176,316 | € 116,814 | € 34,083 | € -202,786 | ▼ € 236,869 |
| Profit after taxes | € -408,675 | € -272,866 | € -705,291 | € -1,147,674 | ▼ € 442,384 |
| Equity | € 512,623 | € 1,246,109 | € 2,558,075 | € 1,328,542 | ▼ 48% |
| Total debts | € 657,364 | € 1,247,253 | € 2,245,394 | € 2,184,993 | ▼ 3% |
| Cash | € 70,205 | € 476,737 | € 2,354,698 | € 698,127 | ▼ 70% |
| Retained profit | € -697,637 | € -970,503 | € -1,675,794 | € -2,823,468 | ▼ € 1.1 million |
| Bank debt | € 75,573 | € 951,136 | € 1,925,219 | € 1,928,705 | |
| Balance sheet total | € 1,169,987 | € 2,493,362 | € 4,803,469 | € 3,513,535 | ▼ 27% |
Key figures of MYOCENE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MYOCENE?
What happened at MYOCENE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- WALLONIE ENTREPRENDRE SA stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 1.1 million. Source: NBB ↗
- PIERRE RIGAUX stepped down as director. NBB
- PIERRE YVES MULLER stepped down as director. NBB
- WALLONIE ENTREPRENDRE SA became a director. NBB
- New establishment in Liège. KBO
- PIERRE RIGAUX became a director. NBB
- PIERRE YVES MULLER became a director. NBB
In short
From € 408,675 loss in 2022 to € 1.1 million loss in 2025.
A new publication or filing at MYOCENE? We notify you, reason included.
Follow MYOCENEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of INVESTSUD comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
MYOCENEThe shares are held by INVESTSUD (4%).
Directors
According to the 2025 annual accounts
since 2020 · until 2026
PIERRE YVES MULLER
Director
since 2020 · until 2026
Director · represented by Sophie SAUVAGE
Also active at: Aciéries Somville, FRANKI, Fonderies J. Marichal Ketin et Cie, TUBES DE HAREN ET NIMY, SOGESTIMMO, T. PALM, NLMK LA LOUVIERE, PLASTURGIE LAZZERINI +46 more
since 2023 · until 2029
Shareholders
4%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue de Spa 2 box 42
4020 Liège
Quai Banning 6
4000 Liège
Active since 5 May 2020
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Google Workspace
Hosting
PLANETHOSTER-8 - PlanetHoster, CA
DNS
GoDaddy DNS
Domain
Domain
myocene.com
Registered
2020-04-02
Registrar
GoDaddy.com, LLC
Expires
2026-04-02
Website info
Features
Security
Details
- Company number
- 0746.696.102
- VAT number
- BE 0746.696.102
- Registered office
- Rue de Spa 2 bus 42, 4020 Liège
- Names & denominations
- MYOCENE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 5 May 2020
- Peppol
- Active · Active since 18 Sept 2025
- Contact
- myocene.com [email protected]
- Activities · NACE
Vervaardiging van bestralingsapparatuur en van elektromedische en elektrotherapeutische apparatuur
Overige niet-gespecialiseerde detailhandel
Groothandel in farmaceutische en medische artikelen
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Overige technische testen en toetsen
Groothandel in andere machines en werktuigen, neg
Groothandel in andere machines en werktuigen, n.e.g.
Detailhandel via postorderbedrijven of via internet